Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
ImExHS Limited ( (AU:IME) ) has provided an announcement.
ImExHS Limited announced a change in the director’s interest, with Douglas Lingard acquiring 26,683 ordinary shares. This acquisition was made in lieu of non-executive director fees for the quarter ending 31 March 2025, reflecting a strategic move to align director interests with company performance.
More about ImExHS Limited
ImExHS Limited operates in the healthcare technology industry, focusing on providing innovative medical imaging solutions. The company offers a range of products and services aimed at enhancing diagnostic capabilities and improving patient outcomes.
YTD Price Performance: 3.95%
Average Trading Volume: 33,851
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$18.36M
See more data about IME stock on TipRanks’ Stock Analysis page.